Potential treatment of breast and lung cancer using dicoma anomala, an african medicinal plant

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

Globally, cancer has been identified as one of the leading causes of death in public health. Its etiology is based on consistent exposure to carcinogenic. Plant‐derived anticancer compounds are known to be less toxic to the normal cells and are classified into acetylenic compounds, phenolics, terpenes, and phytosterols. Dicoma anomala is a perennial herb belonging to the family Asteraceae and is widely distributed in Sub‐Saharan Africa and used in the treatment of cancer, malaria, fever, diabetes, ulcers, cold, and cough. This review aimed at highlighting the benefits of D. anomala in various therapeutic applications with special reference to the treatment of cancers and the mechanisms through which the plant‐derived agents induce cell death.

Original languageEnglish
Article number4435
JournalMolecules
Volume25
Issue number19
DOIs
Publication statusPublished - Oct 2020

Keywords

  • Bioactive compounds
  • Cancer
  • Dicoma
  • Medicinal plants

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Potential treatment of breast and lung cancer using dicoma anomala, an african medicinal plant'. Together they form a unique fingerprint.

Cite this